Back to journals
Academic Journal

Drug and Alcohol Dependence

13 Papers Indexed in Blossom

Data updated

Research Footprint

Drug and Alcohol Dependence has 13 tracked papers indexed in Blossom (1999–2022) from 56 authors, most often covering Ayahuasca, Psilocybin and LSD, across Substance Use Disorders (SUD), PTSD and Depressive Disorders.

Published Papers

Open Accessindividual

Interest in receiving psychedelic-assisted therapy among marginalized women: Implications and findings from a community-based study in Canada

This survey study (n=486) assessed the interest a cohort of marginalized women have in receiving psychedelic-assisted therapy (PAT). Of them, 43% (n=211) were interested in receiving PAT while factors associated with an interest in PAT included daily crystal methamphetamine use, lifetime mental health condition, childhood abuse and lifetime psychedelic use.

Published
Journal
Drug and Alcohol Dependence
Authors
Argento, E., Goldenberg, S., Deering, K., Lavalley, J., Braschel, M., Bingham, B., Shannon, K.
Open Accessindividual

The Effects of MDMA-Assisted Therapy on Alcohol and Substance Use in a Phase 3 Trial for Treatment of Severe PTSD

This trial (n=90) assessed patterns of alcohol and substance use in patients receiving MDMA-assisted therapy. MDMA was associated with a significant reduction in Alcohol Use Disorder Identification Test (AUDIT) scores when compared to placebo. Changes in Drug Use Disorder Identification Test (DUDIT) scores did not significantly differ between groups.

Published
Journal
Drug and Alcohol Dependence
Authors
Nicholas, C. R., Wang, J. B., Coker, A., Mitchell, J., Klaire, S. S., Yazar-Klosinski, B., Emerson, A., Brown, R., Doblin, R.
Open Accessindividual

In vivo effects of 3,4-methylenedioxymethamphetamine (MDMA) and its deuterated form in rodents: Drug discrimination and thermoregulation.

This rat study (n=41) compared the hyperthermic side effects of MDMA ( and a deuterium-substituted analog d2-MDMA in rats and found that d2-MDMA produced increases in body temperature that were shorter-lasting and of lower magnitude compared to equivalent doses of MDMA.

Published
Journal
Drug and Alcohol Dependence
Authors
Berquist, M. D., Leth-Petersen, S., Kristensen, J. L., Fantegrossi, W. E.
Paywallindividual

Psilocybin in long-term meditators: Effects on default mode network functional connectivity and retrospective ratings of qualitative experience

This double-blind, placebo-controlled study (n=16) examined the effects of high-dose psilocybin on subjective experience and brain connectivity in long-term meditators. Results indicate that psilocybin induced profound personal meaning and altered functional connectivity within the default mode network (DMN) and between the DMN and hippocampus, effects that were observable the day after dosing.

Published
Journal
Drug and Alcohol Dependence
Authors
Barrett, F. S., Johnson, M. W., Griffiths, R. R.
Paywallmeta

Ibogaine for treating drug dependence. What is a safe dose?

This review (2016) argues that the current doses of ibogaine administered as a treatment for drug dependence are too high and should be reconsidered to avoid toxicity and fatalities.

Published
Journal
Drug and Alcohol Dependence
Authors
Schep, L. J., Slaughter, R. J., Galea, S., Newcombe, D.
Open Accessindividual

Therapeutic infusions of ketamine: do the psychoactive effects matter?

This double-blind, randomised, inpatient study (n=8) evaluates the mystical and dissociative effects of ketamine in the treatment of cocaine dependant individuals. Ketamine led to significantly greater acute mystical-type effects than the active control, and mediated motivation to quit cocaine 24h post-infusion.

Published
Journal
Drug and Alcohol Dependence
Authors
Dakwar, E., Anerella, C., Hart, C. L., Levin, F. R., Mathew, S. J., Nunes, E. V.

Quick Facts

Papers Indexed
13
h-Index
193
Open Access
No
Publisher
Elsevier
Country
Ireland
Website
Visit